HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LFWD
Lifeward Ltd.
LFWD lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LFWD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
LFWD's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LFWD PE Valuation
LFWD has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LFWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LFWD has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LFWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$17.23 | +$20.45 |
| Q1 2026 | -$20.07 | +$16.65 |
| Q4 2025 | -$18.89 | +$21.07 |
| Q3 2025 | -$35.88 | -$9.36 |
| Q2 2025 | -$37.68 | -$4.44 |
| Q1 2025 | -$36.72 | -$2.76 |
| Q4 2024 | -$39.96 | -$8.88 |
| Q3 2024 | -$26.52 | +$3.72 |
LFWD is still losing money, but far less than before: $17.23 per share over the past year, against $364.56 at its worst in late 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over LFWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over LFWD on profitability, with a higher operating margin.
LFWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +16% |
| Q1 2026 | $3.9M | -22% |
| Q4 2025 | $5.1M | -33% |
| Q3 2025 | $6.2M | +1.1% |
| Q2 2025 | $5.7M | -15% |
| Q1 2025 | $5M | -4.7% |
| Q4 2024 | $7.5M | +9.6% |
| Q3 2024 | $6.1M | +39% |
LFWD's revenue is down over the past year, though its latest quarter was up: $7M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -63% | +52 points |
| Q1 2026 | -264% | -167 points |
| Q4 2025 | -101% | +101 points |
| Q3 2025 | -51% | +1.1 points |
| Q2 2025 | -115% | -48 points |
| Q1 2025 | -96% | +27 points |
| Q4 2024 | -202% | -113 points |
| Q3 2024 | -52% | +129 points |
LFWD's operating margin was −63% last quarter, up 52 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LFWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
LFWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6M | -$2.1M |
| Q1 2026 | -$3.7M | +$1.8M |
| Q4 2025 | -$3.6M | +$403K |
| Q2 2025 | -$3.9M | +$1.7M |
| Q1 2025 | -$5.5M | +$2.2M |
| Q4 2024 | -$4M | +$594K |
| Q2 2024 | -$5.6M | -$2.1M |
| Q1 2024 | -$7.7M | -$2.4M |
LFWD has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LFWD Net Leverage
LFWD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LFWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 22.9 | Neutral |
LFWD's weekly RSI is 39 (neutral) and its Stochastic is 23 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LFWD PE vs Healthcare Sector
LFWD has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LFWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 6.4% below |
| 20 week MA | $6.92 | 17% below |
| 50 week MA | $7.03 | 19% below |
| 100 week MA | $10.4 | 45% below |
| 200 week MA | $32.9 | 83% below |
LFWD is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LFWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $186.5 | $136.1 | -27% |
| 2021 | $136.1 | $113.4 | -17% |
| 2022 | $113.4 | $65.5 | -42% |
| 2023 | $65.5 | $65.4 | -0.2% |
| 2024 | $65.4 | $24.1 | -63% |
| 2025 | $24.1 | $7.73 | -68% |
| 2026 YTD | $7.73 | $5.72 | -26% |
LFWD has the edge over HIMS on returns for 2026, with the stronger performance.